
Kadmon Holdings, Inc. KDMN
Kadmon Holdings, Inc. Finanzkreislauf | KDMN
Finanzkreislauf Jährlich Kadmon Holdings, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.92 | 34.6 | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 34.6 | 3.92 | 19.3 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Taysha Gene Therapies
TSHA
|
-37.8 | $ 4.26 | -0.35 % | $ 1.36 B | ||
|
Reata Pharmaceuticals
RETA
|
-5.6 | - | - | $ 6.29 B | ||
|
PolarityTE
PTE
|
32 | - | -0.82 % | $ 1.78 M | ||
|
United Therapeutics Corporation
UTHR
|
192 | $ 595.86 | 1.23 % | $ 26.4 B | ||
|
Vericel Corporation
VCEL
|
84.2 | $ 59.45 | 0.7 % | $ 2.99 B | ||
|
Veracyte
VCYT
|
29.9 | $ 25.08 | 4.24 % | $ 1.97 B | ||
|
Advaxis
ADXS
|
-82.3 K | - | -9.65 % | $ 45.9 M | ||
|
CNS Pharmaceuticals
CNSP
|
-13.6 K | $ 3.62 | -5.97 % | $ 1.6 M | ||
|
Trevena
TRVN
|
-412 | - | -46.58 % | $ 31.8 M | ||
|
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | ||
|
Wave Life Sciences Ltd.
WVE
|
11.5 | $ 3.42 | -0.15 % | $ 577 M | ||
|
Exicure
XCUR
|
-4.16 | $ 1.05 | -2.78 % | $ 6.61 M | ||
|
Xeris Pharmaceuticals
XERS
|
535 | $ 16.51 | 4.3 % | $ 2.65 B | ||
|
Molecular Templates
MTEM
|
4.53 | - | -23.43 % | $ 495 K | ||
|
22nd Century Group
XXII
|
108 | $ 1.57 | 10.56 % | $ 289 K | ||
|
Zai Lab Limited
ZLAB
|
-46.6 | $ 26.42 | -0.04 % | $ 28.9 B | ||
|
Zoetis
ZTS
|
317 | $ 82.56 | 0.12 % | $ 36.6 B | ||
|
BioXcel Therapeutics
BTAI
|
-32.5 K | $ 0.07 | 9.81 % | $ 855 K | ||
|
Navidea Biopharmaceuticals
NAVB
|
-279 K | - | -2.99 % | $ 2.47 M | ||
|
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | ||
|
Insmed Incorporated
INSM
|
173 | $ 120.63 | 0.95 % | $ 24 B | ||
|
Novan
NOVN
|
-159 | - | -24.84 % | $ 2.64 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
bluebird bio
BLUE
|
72.4 | - | - | $ 546 M | ||
|
Intra-Cellular Therapies
ITCI
|
257 | - | - | $ 13.6 B | ||
|
Marinus Pharmaceuticals
MRNS
|
59.8 | - | - | $ 29.6 M | ||
|
NeuBase Therapeutics
NBSE
|
-65.8 | - | -1.56 % | $ 12.3 M | ||
|
CASI Pharmaceuticals
CASI
|
126 | - | - | $ 35.4 M | ||
|
ContraFect Corporation
CFRX
|
-1.83 K | - | -5.16 % | $ 5.39 M | ||
|
Sigilon Therapeutics
SGTX
|
31.4 | - | - | $ 728 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M |